Regeneron's quarterly profit tops estimates on Eylea sales
(Reuters) - Regeneron Pharmaceuticals Inc reported a better-than-expected quarterly profit on Wednesday, helped by higher sales of its flagship eye treatment Eylea.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Health | Profits and Losses